Omega-3 LC-PUFA supply and neurological outcomes in children with phenylketonuria (PKU)

Journal of Pediatric Gastroenterology and Nutrition

Volumn 48, Issue SUPPL. 1, 2009, Pages

  Koletzko, Berthold ^a   Beblo, Skadi ^a   Demmelmair, Hans ^a   Hanebutt, Fabienne L ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Arachidonic acid; Docosahexaenoic acid; Phenylketonuria; Potential latencies; Rostock Oseretzky test; Visual evoked

Indexed keywords

CERVONIC ACID; FISH OIL; LINOLENIC ACID; OMEGA 3 FATTY ACID; PHENYLALANINE;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; EVOKED VISUAL RESPONSE; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; HUMAN; MOTOR PERFORMANCE; NEUROLOGIC DISEASE; PHENYLKETONURIA; PRIORITY JOURNAL; PROTEIN INTAKE; BLOOD; DIET THERAPY; DRUG EFFECT; FEMALE; INFANT; MALE; NUTRITIONAL REQUIREMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; REVIEW;

CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; HUMANS; INFANT; MALE; MOTOR SKILLS; NERVOUS SYSTEM DISEASES; NUTRITIONAL REQUIREMENTS; PHENYLALANINE; PHENYLKETONURIAS;

EID: 66149087737     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181977399     Document Type: Article

References (42)

1. Sprecher H. Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta 2000;1486:219-31.
2. Sprecher H. The roles of anabolic and catabolic reactions in the synthesis and recycling of polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 2002;67:79-83.
3. Sauerwald TU, Hachey DL, Jensen CL, et al. New insights into the metabolism of long chain polyunsaturated fatty acids during infancy. Eur J Med Res 1997;2:88-92.
4. Nakamura MT, Cho HP, Xu J, et al. Metabolism and functions of highly unsaturated fatty acids: an update. Lipids 2001;36:961-4.
5. Rosell MS, Lloyd-Wright Z, Appleby PN, et al. Long-chain n-3 polyunsaturated fatty acids in plasma in British meat-eating, vegetarian, and vegan men. Am J Clin Nutr 2005;82:327-34.
6. Plourde M, Cunnane SC. Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 2007;32:619-34.
7. Koletzko B, Edenhofer S, Lipowsky G, et al. Effects of a low birthweight infant formula containing human milk levels of docosahexaenoic and arachidonic acids. J Pediatr Gastroenterol Nutr 1995;21:200-8.
8. Koletzko B, Agostoni C, Carlson SE, et al. Long chain polyunsaturated fatty acids (LC-PUFA) and perinatal development. Acta Paediatr 2001;90:460-4. (Pubitemid 32328472)
9. Schaeffer L, Gohlke H, Muller M, et al. Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum Mol Genet 2006;15:1745-56.
10. Geppert J, Kraft V, Demmelmair H, et al. Docosahexaenoic acid supplementation in vegetarians effectively increases omega-3 index: a randomized trial. Lipids 2005;40:807-14.
11. Harris WS, Pottala JV, Sands SA, et al. Comparison of the effects of fish and fish-oil capsules on the n 3 fatty acid content of blood cells and plasma phospholipids. Am J Clin Nutr 2007;86:1621-5.
12. Salem N Jr, Litman B, Kim HY, et al. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 2001; 36:945-59.
13. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008;8:349-61.
14. Calder PC. Fatty acids and gene expression related to inflammation. Nestle Nutr Workshop Ser Clin Perform Programme 2002;7:19-36.
15. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008;8:349-61.
16. Koletzko B, Lien E, Agostoni C, et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med 2008;36:5-14.
17. Atkinson SA, Koletzko B. Determining life-stage groups and extrapolating nutrient intake values (NIVs). Food Nutr Bull 2007;28:S61-76.
18. Astorg P, Arnault N, Czernichow S, et al. Dietary intakes and food sources of n-6 and n-3 PUFA in French adult men and women. Lipids 2004;39:527-35.
19. Kornsteiner M, Singer I, Elmadfa I. Very low n-3 long-chain polyunsaturated fatty acid status in Austrian vegetarians and vegans. Ann Nutr Metab 2008;52:37-47.
20. Christ SE. Asbjorn Folling and the discovery of phenylketonuria. J Hist Neurosci 2003;12:44-54.
21. Erlandsen H, Stevens RC. The structural basis of phenylketonuria. Mol Genet Metab 1999;68:103-25.
22. Eisensmith RC, Woo SL. Molecular basis of phenylketonuria and relatedhyperphenylalaninemias:mutations andpolymorphismsin the human phenylalanine hydroxylase gene. Hum Mutat 1992;1:13-23.
23. Scriver CRKS. The hyperphenylalaninemias. In The Metabolic and Molecular Bases of Inherited Disease. NewYork: McGraw-Hill; 1995.
24. Macdonald A. Diet and compliance in phenylketonuria. Eur J Pediatr 2000;159 (Suppl 2):S136-41.
25. Koletzko B, Sauerwald T, Demmelmair H, et al. Dietary long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria: a randomized controlled trial. J Inherit Metab Dis 2007;30:326-32.
26. Sanjurjo P, Perteagudo L, Rodriguez Soriano J, et al. Polyunsaturated fatty acid status in patients with phenylketonuria. J Inherit Metab Dis 1994;17:704-9.
27. Galli C, Agostoni C, Mosconi C, et al. Reduced plasma C-20 and C-22 polyunsaturated fatty acids in children with phenylketonuria during dietary intervention. J Pediatr 1991;119:562-7.
28. Giovannini M, Biasucci G, Agostoni C, et al. Lipid status and fatty acid metabolism in phenylketonuria. J Inherit Metab Dis 1995;18:265-72.
29. Infante JP, Huszagh VA. Impaired arachidonic (20:4n-6) and docosahexaenoic (22:6n-3) acid synthesis by phenylalanine metabolites as etiological factors in the neuropathology of phenylketonuria. Mol Genet Metab 2001;72:185-98.
30. Poge AP, Baumann K, Muller E, et al. Long-chain polyunsaturated fatty acids in plasma and erythrocyte membrane lipids of children with phenylketonuria after controlled linoleic acid intake. J Inherit Metab Dis 1998;21:373-81.
31. van Gool CJ, van Houwelingen AC, Hornstra G. The essential fatty acid status in phenylketonuria patients under treatment. J Nutr Biochem 2000;11:543-7.
32. Burgard P, Schmidt E, Rupp A, et al. Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria. Eur J Pediatr 1996;155 (Suppl 1):S33-8.
33. Stemerdink BA, Kalverboer AF, van der Meere JJ, et al. Behaviour and school achievement in patients with early and continuously treated phenylketonuria. J Inherit Metab Dis 2000;23:548-62.
34. Agostoni C, Riva E, Biasucci G, et al. The effects of n-3 and n-6 polyunsaturated fatty acids on plasma lipids and fatty acids of treated phenylketonuric children. Prostaglandins Leukot Essent Fatty Acids 1995;53:401-4.
35. Innis SM, Nelson CM, Rioux MF, et al. Development of visual acuity in relation to plasma and erythrocyte omega-6 and omega-3 fatty acids in healthy term gestation infants. Am J Clin Nutr 1994;60:347-52.
36. Luukkainen P, Salo MK, Visakorpi JK, et al. Impact of solid food on plasma arachidonic and docosahexaenoic acid status of term infants at 8 months of age. J Pediatr Gastroenterol Nutr 1996; 23:229-34.
37. Agostoni C, Harvie A, McCulloch DL, et al. A randomized trial of long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria. Dev Med Child Neurol 2006;48:207-12.
38. Agostoni C, Massetto N, Biasucci G, et al. Effects of long-chain polyunsaturated fatty acid supplementation on fatty acid status and visual function in treated children with hyperphenylalaninemia. J Pediatr 2000;137:504-9.
39. Henderson RM, McCulloch DL, Herbert AM, et al. Visual eventrelated potentials in children with phenylketonuria. Acta Paediatr 2000;89:52-7.
40. Leuzzi V, Rinalduzzi S, Chiarotti F, et al. Subclinical visual impairment in phenylketonuria. A neurophysiological study (VEP-P) with clinical, biochemical, and neuroradiological (MRI) correlations. J Inherit Metab Dis 1998;21:351-64.
41. Beblo S, Reinhardt H, Muntau AC, et al. Fish oil supplementation improves visual evoked potentials in children with phenylketonuria. Neurology 2001;57:1488-91.
42. Beblo S, Reinhardt H, Demmelmair H, et al. Effect of fish oil supplementation on fatty acid status, coordination, and fine motor skills in children with phenylketonuria. J Pediatr 2007; 150:479-84.